Cambridge capitalises on booming biomedical campus
Cambridge is capitalising on its reputation in the medical science and technology sectors, winning international conferences that will bring more than 3,000 delegates and £3.2 million in economic impact over the next two years.
Cambridge is at the centre of Europe’s leading bioscience and healthcare cluster, with the Cambridge Biomedical Campus currently undergoing a major expansion which will see it become one of the world’s leading biomedical centres by 2020.
Meet Cambridge, the conference and events bureau for the region, has recently confirmed 14 high profile international meetings for the UK city, with at least five further international events up to 2024 currently in the pipeline.
Judith Sloane, Deputy Manager at Meet Cambridge said: “Most of these events are from the medical, technology and scientific sectors, for which Cambridge can deliver unique benefits in terms of tapping into the local expertise at our universities and the knowledge clusters at our science and technology parks, Addenbrooke’s Hospital and the new Biomedical Campus. All of these offer excellent opportunities for collaboration, peer-to-peer networking.”
The first phase of the Cambridge Biomedical Campus expansion supported the growth of AstraZeneca, Cambridge University Hospitals NHS Foundation Trust, The University of Cambridge, the Medical Research Council’s Laboratory of Molecular Biology and the New Royal Papworth Hospital, the UK’s leading heart and lung hospital.
As part of the second phase, Abcam, a global innovator in life science reagents and tools, is building a new state-of-the-art global headquarters on campus.
The campus also accommodates the MRC Laboratory for Molecular Biology, Cancer Research UK Institute, the Institute of Metabolic Science as well as the Rosie and Addenbrooke’s Hospitals. A number of world-class science parks are located on the outskirts of the city including the Cambridge Science Park, Babraham Institute, the Wellcome Genome Campus and St John’s Innovation Centre.
Over 339 of the world’s leading biomedical and healthcare companies have made Cambridge their home, with the sector employing more than 12,000 people and posting a collective turnover of over £2bn.
Andrew Blevins, managing director of Liberty Property Trust, joint developers of Cambridge Biomedical Campus, said: “Abcam’s approach to innovation and collaboration makes it a perfect addition to the vibrant life sciences community at Cambridge Biomedical Campus, where breakthrough ideas can transition from the researcher’s bench to the patient’s bedside all on the same site. We are continuing to work to ensure this unique mix of world-class academics, businesses and clinicians can grow and thrive, providing the bespoke facilities and jobs needed to make CBC and the UK life sciences sector a global leader in healthcare research.”
Conferences already hosted in Cambridge in 2019 include: International Biocuration Conference; and the Annual Workshop Mathematical and Statistical Aspects of Molecular Biology and Evolution Evolving.
Upcoming meetings include: International Conference on Affective Computing and Intelligent Interaction; The Association for Computing Machinery International Conference on Human Robotic Interaction; the 20th biennial congress of the European Psychiatric Association Section of Epidemiology & Social Psychiatry and the 11th International Symposium on Veterinary Rehabilitation and Physical Therapy.
Published Date: 02/07/2019